The facility incorporates best practices and insights from across the company’s manufacturing division network.

Merck posted strong Q4 earnings, with a 7% revenue increase to $15.62 billion, beating expectations. Growth was driven by ...

Dr. Chandler Park helps patients with genitourinary cancers, including both prostate and bladder, understand the importance ...

Around the world, events are being held to mark Rare Disease Day (28 February 2025), with the aim of bringing attention to ...

Genitourinary Cancer Symposium 2025, held on 13-15 February, final results from the randomised, multicentre, double-blind, ...

Manitoba has become the first province to sign a pharmacare agreement with the federal government. The province will be getting $219 million over four years for universal coverage for diabetes ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

I recommend accumulating shares of Merck and Procter & Gamble in 2025, leveraging the Dogs of the Dow strategy for a combination of value and growth. Merck is undervalued with strong fundamentals ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...

Adjusted operating loss is expected to be less than $495 million. EU Approval to Merck’s Welireg for Two Indications The European Commission approved Merck’s Welireg as a monotherapy for ...

It's making rapid progress with Welireg as well. But what does any of that have to do with owning this dividend-paying stock forever? The point is, while it may not be a high-growth name and will ...